炎症性疾患患者における血清アミロイドA蛋白の高比重リポ蛋白におよぼす影響 enzyme-linked immunosorbent assayによる検討

Saved in:
Bibliographic Details
Published in動脈硬化 Vol. 20; no. 2-3; pp. 101 - 109
Main Authors 公文, 義雄, 吉田, 健三, 池田, 幸雄, 大野, 文俊, 末廣, 正
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本動脈硬化学会 01.03.1992
Online AccessGet full text
ISSN0386-2682
2185-8284
DOI10.5551/jat1973.20.2-3_101

Cover

Author 末廣, 正
大野, 文俊
公文, 義雄
池田, 幸雄
吉田, 健三
Author_xml – sequence: 1
  fullname: 公文, 義雄
  organization: 高知医科大学第二内科
– sequence: 1
  fullname: 吉田, 健三
  organization: 高知医科大学第二内科
– sequence: 1
  fullname: 池田, 幸雄
  organization: 高知医科大学第二内科
– sequence: 1
  fullname: 大野, 文俊
  organization: 高知医科大学第二内科
– sequence: 1
  fullname: 末廣, 正
  organization: 高知医科大学第二内科
BookMark eNo9kM1Kw0AAhBdRsNa-gO-Qur_J5liKVqHgRc9h02y0pVZJevHWJJSqRUEQtYgUf0CwqHjzYPVhFpP2LQxaCwMDwzdzmAUw29hrSACWEMwzxtByTTSRaZA8hnmsEQtBNAMyGHGmcczpLMhAwnUN6xzPg5zvV20IoWmkAM6AWhKeJpeduPWYXHzG4X2qUautgoEKjlVwpsLu6LYVv7dVeKeivoqeVfigoqPC6Lqb9IYqeBkPruLX83HnREVPKrr5z3_74aEKPlTQ-x6-jftfi2DOFXVf5iaeBVurK5vFNa28UVovFspaDVEmNOZKrBOTYuZi6nBJDZNwQiWEktrMcSqQGMzUmWlDUziOS11kG64hEdS5w6AkWVD62635TbEtrX2vuiu8A0t4zWqlLq3JXRaGFramlr42JSo7wksx8gPu5owE
ContentType Journal Article
Copyright 一般社団法人 日本動脈硬化学会
Copyright_xml – notice: 一般社団法人 日本動脈硬化学会
DOI 10.5551/jat1973.20.2-3_101
DeliveryMethod fulltext_linktorsrc
EISSN 2185-8284
EndPage 109
ExternalDocumentID article_jat1973_20_2_3_20_2_3_101_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
ID FETCH-LOGICAL-j145a-5fe2639425f24d8e4793834e00e4b5ddc03759659b09addf4f1b7f7e1068d50e3
ISSN 0386-2682
IngestDate Wed Sep 03 06:25:25 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2-3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j145a-5fe2639425f24d8e4793834e00e4b5ddc03759659b09addf4f1b7f7e1068d50e3
OpenAccessLink https://www.jstage.jst.go.jp/article/jat1973/20/2-3/20_2-3_101/_article/-char/ja
PageCount 9
ParticipantIDs jstage_primary_article_jat1973_20_2_3_20_2_3_101_article_char_ja
PublicationCentury 1900
PublicationDate 1992/03/01
PublicationDateYYYYMMDD 1992-03-01
PublicationDate_xml – month: 03
  year: 1992
  text: 1992/03/01
  day: 01
PublicationDecade 1990
PublicationTitle 動脈硬化
PublicationTitleAlternate 動脈硬化
PublicationYear 1992
Publisher 一般社団法人 日本動脈硬化学会
Publisher_xml – name: 一般社団法人 日本動脈硬化学会
References 22) Coetzee, G. A., Strachan, A. F., van der Westhuyzen, D. R., Hoppe, H. C., Jeenah, M. S. and de Beer, F. C.: Serum amyloid A-containing human high density lipoprotein 3. density, size, and apolipoprotein composition. J. Biol. Chem., 261: 9644-9651 (1986).
28) Joven, J., Rubiés-Prat, J., Ras, M. R., de la Figuerar, M., Lience, E and Masdeu, S.: High density lipoprotein cholesterol subfractions and apoprotein A-I in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis. Rheum., 27: 1199-1200 (1984)..
10) Havel, R. J., Eder, H. A. and Bragdon, J. H.: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest., 34: 1345-1353 (1955).
14) Sipe, J. D., Gonnerman, W. A., Loose, L. D., Knapschaefer, G., Xie, W. -J. and Franzblau, C.: Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J. Immunol. Methods, 125: 125-135 (1989).
16) Brewer, H. B., Jr., Ronan, R., Meng, M, and Bishop, C.: Isolation and characterization of apolipoproteins A-I, A-II, and A-IV. In Methods in Enzymology 128 (Segrest, J. P. and Albers, J. J., eds.), Academic Press, London, pp. 223-246 (1986).
7) Benditt, E. P. and Eriksen, N.: Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sci. U. S. A., 74: 4025-4028 (1977).
13) Ishikawa, E., Imagawa, M., Hashida, S., Hamaguchi, Y. and Ueno, T.: Enzyme-labeling of anitbodies and their fragments for enzyme immunoassay and immunohistochemical staining. J. Immunoassay, 4: 209-327 (1983).
18) Rall, S.C., Jr., Weisgraber, K. H, and Mahley, R. W. Isolation and characterization of apolipoprotein E. In Methods in Enzymology 128 (Segrest, J. P, and Albers, J. J., eds.), Academic Press, London, pp. 273-287 (1986).
20) Marhaug, G.: Three assays for the characterization and quantitation of human serum amyloid A. Scand. J. Immunol., 18: 329-338 (1983).
8) 公文義雄, 吉田健三, 末廣正, 大野文俊: 急性心筋梗塞患者のHDL分画にみられるserum amyloid A proteinの変動. 動脈硬化, 15: 1197-1206 (1987).
25) Steinmetz, A., Kocke, G., Saïle, R., Puchois, P. and. Fruchart, J. -C.: Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim. Biophys. Acta, 1006: 173-178 (1989).
24) Cabana, V. G., Siegel, J. N. and Sabesin, S. M.: Abnormal HDL generated during the acute phase response. Arteriosclerosis, 10: 764 (1990).
4) Rosenthal, C. J. and Sullivan, L. M.: Serum amyloid Ato monitor cancer dissemination. Ann. Intern. Med., 91: 383-390 (1979).
9) 吉田健三, 末廣正, 安岡伸和, 公文義雄, 大野文俊: 急性心筋梗塞のHDL分画内およびヒト粥状硬化巣における血清アミロイドA蛋白の検討. 動脈硬化, 16: 505-515 (1988).
1) Anders, R. F., Natvig, J. B., Michaelsen, T. E. and Husby, G.: Isolation and characterization of amyloidrelated serum protein SAA as a low molecular weight protein. Scand. J. Immunol., 4: 397-401 (1975).
3) Eriksen, N. and Benditt, E. P.: Trauma, high density lipoproteins, and serum amyloid protein A. Clin. Chim. Acta, 140: 139-149 (1984).
19) 中西俊明, 赤沢昭一, 遠山杏子, 三宅清兵衛, 長瀧重信: RIA法によるapo A-I, A-IIの測定と臨床応用. 臨床病理, 31: 126-131 (1983).
29) Isomäki, H. A., Mutru, O. and Koota, K.: Death rate and causes of death in patients with rheumatoid arthritis. Scand. J. Rheumatology, 4: 205-208 (1975).
15) Fenner, C., Traut, R. R., Mason, D. T. and WikmanCoffelt, J.: Quantification of Coomassie blue stained proteins in polyacrylamide gels based on analysis of eluted dye. Anal. Biochem., 63: 595-602 (1975).
30) Monson, R. R, and Hall, A. P.: Mortality among arthritics. J. Chron. Dis., 29: 459-467 (1976).
27) Rössner, S. and Löfmark, C.: Dyslipoproteinaemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis, 28: 41-52 (1977).
23) Husebekk, A., Skogen, B. and Husby, G.: Highdensity lipoprotein has different binding capacity for different apoproteins. Scand. J. Immunol., 28: 653-658 (1988).
12) Raynes, J. G. and McAdam, K. P. W. J.: Purification of serum amyloid A and other high density apolipoproteins by hydrophobic interaction chromatography. Anal. Biochem., 173: 116-124 (1988).
21) Chambers, R. E. and Whicher, J. T.: Quantitative radial immunodiffusion assay for serum amyloid A protein. J. Immunol. Methods, 59: 95-103 (1983).
2) Rosenthal, C. J. and Franklin, E. C.: Variation with age and disease of an amyloid A protein-related serum component. J. Clin. Invest., 55: 746-753 (1975).
5) McAdam, K. P. W. J., Elin, R. J., Sipe, J. D. and Wolff, S. M.: Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J. Clin. Invest., 61: 390-394 (1978).
31) Zimlichman, S., Danon, A., Nathan, I., Mozes, G. and Shainkin-Kestenbaum, R.: Serum amyloid A, an acute phase protein, inhibits platelet activation. J. Lab. Clin. Med., 116: 180-186 (1990).
11) 川田益意, 末廣正, 高松和永, 安岡伸和, 吉田健三, 岸野和貴子, 久武邦彦, 宇賀茂敏, 山野利尚, 大野文俊: デキストラン硫酸沈澱法によるHDL2-, HDL3-Cholesterol測定の検討と臨床成績. 動脈硬化, 12: 887-894 (1984).
17) Jackson, R. L. and Holdsworth, G.: Isolation and properties of human apolipoproteins C-I, C-II, and C-III. In Methods in Enzymology 128 (Segrest, J. P. and Albers, J. J., eds.), Academic Press, London, pp. 288-297 (1986).
26) Marhaug, G. and Husby, G.: Characterization of human amyloid-related protein SAA as a polymorphic protein: association with albumin and prealbumin in serum. Clin. Exp. Immunol., 45: 97-106 (1981).
32) 板原隆, 公文義雄, 池田幸雄, 末廣正, 吉田健三, 安岡伸和, 川田益意, 山野利尚, 大野文俊: 血清アミロイドA蛋白 (SAA) の血小板凝集能におよぼす影響. 動脈硬化, 19: 478 (1991).
6) Maury, C. P. J.: Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin. Sci., 68: 233-238 (1985).
References_xml – reference: 6) Maury, C. P. J.: Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin. Sci., 68: 233-238 (1985).
– reference: 31) Zimlichman, S., Danon, A., Nathan, I., Mozes, G. and Shainkin-Kestenbaum, R.: Serum amyloid A, an acute phase protein, inhibits platelet activation. J. Lab. Clin. Med., 116: 180-186 (1990).
– reference: 18) Rall, S.C., Jr., Weisgraber, K. H, and Mahley, R. W. Isolation and characterization of apolipoprotein E. In Methods in Enzymology 128 (Segrest, J. P, and Albers, J. J., eds.), Academic Press, London, pp. 273-287 (1986).
– reference: 23) Husebekk, A., Skogen, B. and Husby, G.: Highdensity lipoprotein has different binding capacity for different apoproteins. Scand. J. Immunol., 28: 653-658 (1988).
– reference: 8) 公文義雄, 吉田健三, 末廣正, 大野文俊: 急性心筋梗塞患者のHDL分画にみられるserum amyloid A proteinの変動. 動脈硬化, 15: 1197-1206 (1987).
– reference: 17) Jackson, R. L. and Holdsworth, G.: Isolation and properties of human apolipoproteins C-I, C-II, and C-III. In Methods in Enzymology 128 (Segrest, J. P. and Albers, J. J., eds.), Academic Press, London, pp. 288-297 (1986).
– reference: 25) Steinmetz, A., Kocke, G., Saïle, R., Puchois, P. and. Fruchart, J. -C.: Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim. Biophys. Acta, 1006: 173-178 (1989).
– reference: 22) Coetzee, G. A., Strachan, A. F., van der Westhuyzen, D. R., Hoppe, H. C., Jeenah, M. S. and de Beer, F. C.: Serum amyloid A-containing human high density lipoprotein 3. density, size, and apolipoprotein composition. J. Biol. Chem., 261: 9644-9651 (1986).
– reference: 9) 吉田健三, 末廣正, 安岡伸和, 公文義雄, 大野文俊: 急性心筋梗塞のHDL分画内およびヒト粥状硬化巣における血清アミロイドA蛋白の検討. 動脈硬化, 16: 505-515 (1988).
– reference: 5) McAdam, K. P. W. J., Elin, R. J., Sipe, J. D. and Wolff, S. M.: Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation. J. Clin. Invest., 61: 390-394 (1978).
– reference: 11) 川田益意, 末廣正, 高松和永, 安岡伸和, 吉田健三, 岸野和貴子, 久武邦彦, 宇賀茂敏, 山野利尚, 大野文俊: デキストラン硫酸沈澱法によるHDL2-, HDL3-Cholesterol測定の検討と臨床成績. 動脈硬化, 12: 887-894 (1984).
– reference: 13) Ishikawa, E., Imagawa, M., Hashida, S., Hamaguchi, Y. and Ueno, T.: Enzyme-labeling of anitbodies and their fragments for enzyme immunoassay and immunohistochemical staining. J. Immunoassay, 4: 209-327 (1983).
– reference: 10) Havel, R. J., Eder, H. A. and Bragdon, J. H.: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest., 34: 1345-1353 (1955).
– reference: 19) 中西俊明, 赤沢昭一, 遠山杏子, 三宅清兵衛, 長瀧重信: RIA法によるapo A-I, A-IIの測定と臨床応用. 臨床病理, 31: 126-131 (1983).
– reference: 7) Benditt, E. P. and Eriksen, N.: Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sci. U. S. A., 74: 4025-4028 (1977).
– reference: 14) Sipe, J. D., Gonnerman, W. A., Loose, L. D., Knapschaefer, G., Xie, W. -J. and Franzblau, C.: Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J. Immunol. Methods, 125: 125-135 (1989).
– reference: 4) Rosenthal, C. J. and Sullivan, L. M.: Serum amyloid Ato monitor cancer dissemination. Ann. Intern. Med., 91: 383-390 (1979).
– reference: 16) Brewer, H. B., Jr., Ronan, R., Meng, M, and Bishop, C.: Isolation and characterization of apolipoproteins A-I, A-II, and A-IV. In Methods in Enzymology 128 (Segrest, J. P. and Albers, J. J., eds.), Academic Press, London, pp. 223-246 (1986).
– reference: 1) Anders, R. F., Natvig, J. B., Michaelsen, T. E. and Husby, G.: Isolation and characterization of amyloidrelated serum protein SAA as a low molecular weight protein. Scand. J. Immunol., 4: 397-401 (1975).
– reference: 3) Eriksen, N. and Benditt, E. P.: Trauma, high density lipoproteins, and serum amyloid protein A. Clin. Chim. Acta, 140: 139-149 (1984).
– reference: 12) Raynes, J. G. and McAdam, K. P. W. J.: Purification of serum amyloid A and other high density apolipoproteins by hydrophobic interaction chromatography. Anal. Biochem., 173: 116-124 (1988).
– reference: 15) Fenner, C., Traut, R. R., Mason, D. T. and WikmanCoffelt, J.: Quantification of Coomassie blue stained proteins in polyacrylamide gels based on analysis of eluted dye. Anal. Biochem., 63: 595-602 (1975).
– reference: 24) Cabana, V. G., Siegel, J. N. and Sabesin, S. M.: Abnormal HDL generated during the acute phase response. Arteriosclerosis, 10: 764 (1990).
– reference: 27) Rössner, S. and Löfmark, C.: Dyslipoproteinaemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis, 28: 41-52 (1977).
– reference: 29) Isomäki, H. A., Mutru, O. and Koota, K.: Death rate and causes of death in patients with rheumatoid arthritis. Scand. J. Rheumatology, 4: 205-208 (1975).
– reference: 26) Marhaug, G. and Husby, G.: Characterization of human amyloid-related protein SAA as a polymorphic protein: association with albumin and prealbumin in serum. Clin. Exp. Immunol., 45: 97-106 (1981).
– reference: 30) Monson, R. R, and Hall, A. P.: Mortality among arthritics. J. Chron. Dis., 29: 459-467 (1976).
– reference: 20) Marhaug, G.: Three assays for the characterization and quantitation of human serum amyloid A. Scand. J. Immunol., 18: 329-338 (1983).
– reference: 21) Chambers, R. E. and Whicher, J. T.: Quantitative radial immunodiffusion assay for serum amyloid A protein. J. Immunol. Methods, 59: 95-103 (1983).
– reference: 32) 板原隆, 公文義雄, 池田幸雄, 末廣正, 吉田健三, 安岡伸和, 川田益意, 山野利尚, 大野文俊: 血清アミロイドA蛋白 (SAA) の血小板凝集能におよぼす影響. 動脈硬化, 19: 478 (1991).
– reference: 2) Rosenthal, C. J. and Franklin, E. C.: Variation with age and disease of an amyloid A protein-related serum component. J. Clin. Invest., 55: 746-753 (1975).
– reference: 28) Joven, J., Rubiés-Prat, J., Ras, M. R., de la Figuerar, M., Lience, E and Masdeu, S.: High density lipoprotein cholesterol subfractions and apoprotein A-I in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis. Rheum., 27: 1199-1200 (1984)..
SSID ssib000972182
ssj0003239275
ssib002821934
Score 1.3863703
SourceID jstage
SourceType Publisher
StartPage 101
Subtitle enzyme-linked immunosorbent assayによる検討
Title 炎症性疾患患者における血清アミロイドA蛋白の高比重リポ蛋白におよぼす影響
URI https://www.jstage.jst.go.jp/article/jat1973/20/2-3/20_2-3_101/_article/-char/ja
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 動脈硬化, 1992/03/01, Vol.20(2-3), pp.101-109
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2185-8284
  dateEnd: 20021231
  omitProxy: true
  ssIdentifier: ssj0003239275
  issn: 0386-2682
  databaseCode: KQ8
  dateStart: 19730101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Na9RAFA-1XryIouI3PTgnyZpMZpKZm5PdLEVREFroLWx2s8Ieqsj24qm7S6laFARRi0jxAwSLijcPVv-Ywd32v_C9SbJNbUWrELJvX9785s17ycy8YT4s60LqMZpCw2UnraZjM97mdoOlDZslTc5FwtyGOSXi2nV_epZdmeNzE5M3S7OWFrpJpXl3z3Ul_-JV4IFfcZXsPjw7BgUG0OBfuIOH4f5XPiZRQAQlIkJCAh2QyMe5CyowHJ-EkeFQorwSIVBGcBJ50JEkKswJoXJCuoYA5BCFlYvykDwURSrAoYbwiKznhKoVj1jOEVJhehkaIFBIkrBW5AqaScxbCoRWdSIZcqAMolYgqiKP2u9xftEelBY5J6wW5ZEk4pgkdDEL0DjcMZ0RnwKy5MY0zCAEWGxVNY-qRI4HMA2Dmyc-WhgHU6oXUR5sraTBBz1ZWV6CtaVRnJHQyeS5UR5yZMasclveRzWVs0s-lCi5Fz4YHD2eGS_K5AvlEL8Oxtke3smmAnvl4Z1CC8cYQJjSBQiL7w_HDLP3J_SMkYCv4MpyCUwpgKgW5vqDJY3GNaJ8AwQcVWqNPOHb1M9OiqqkhgfdQ477ELByc0qdUrVBba_UOrp5wdL8n9yrDefQhzdnR3RdGXgV6lQAJB4n3bE3ev7lxblwTJ2YxuMfSBMXEriGEcQOWAcpNP94xsvVG6U4BPewEjumF0Bgw8aDtR6FMMJs2j02Q7YAD5W9tFtV6M52ILgrJoaavurMEetwHmROqUyro9ZEp3HM6oz6j0bPloeL70ZPvw37b-DaXFzSvXXde6B7j3V_ZfPV4vDLku6_1oM1Pfig-2_14L7afLEyWt3QvY9b68-Hn55sLT_Ug_d68LLgm_T9e7r3VfdWf2x83lr7ftyarUcz1Wk7P2nF7riMN2zeTimEKtB-tylriRSH24XHUsdJWcJbUI17AcetRxNHQoeozdpuErQDqOR90eJO6p2wJudvzacnram02ZK8waBrkAio-lnSTloQA0Ag79HUYckp63Jmmvh2tp1OvG8nnv5_iDPWoe2P7aw12b2zkJ6D6KKbnDdvxk-7ke4e
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%82%8E%E7%97%87%E6%80%A7%E7%96%BE%E6%82%A3%E6%82%A3%E8%80%85%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%A1%80%E6%B8%85%E3%82%A2%E3%83%9F%E3%83%AD%E3%82%A4%E3%83%89A%E8%9B%8B%E7%99%BD%E3%81%AE%E9%AB%98%E6%AF%94%E9%87%8D%E3%83%AA%E3%83%9D%E8%9B%8B%E7%99%BD%E3%81%AB%E3%81%8A%E3%82%88%E3%81%BC%E3%81%99%E5%BD%B1%E9%9F%BF&rft.jtitle=%E5%8B%95%E8%84%88%E7%A1%AC%E5%8C%96&rft.au=%E5%85%AC%E6%96%87%2C+%E7%BE%A9%E9%9B%84&rft.au=%E5%90%89%E7%94%B0%2C+%E5%81%A5%E4%B8%89&rft.au=%E6%B1%A0%E7%94%B0%2C+%E5%B9%B8%E9%9B%84&rft.au=%E5%A4%A7%E9%87%8E%2C+%E6%96%87%E4%BF%8A&rft.date=1992-03-01&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%8B%95%E8%84%88%E7%A1%AC%E5%8C%96%E5%AD%A6%E4%BC%9A&rft.issn=0386-2682&rft.eissn=2185-8284&rft.volume=20&rft.issue=2-3&rft.spage=101&rft.epage=109&rft_id=info:doi/10.5551%2Fjat1973.20.2-3_101&rft.externalDocID=article_jat1973_20_2_3_20_2_3_101_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0386-2682&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0386-2682&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0386-2682&client=summon